
A rare, giant starfish could hold the key to restoring kelp forests on the California coast
Ashley Kidd signed onto the Zoom call a few minutes late, giddily explaining that 12 minutes ago there was an unexpected development in a planned spawn of critically endangered starfish.
Kidd, conservation project manager with the Sunflower Star Laboratory in the Monterey Bay area, was part of a squad set to travel to an aquarium in Alaska, where the plan was to inject the facility's sunflower sea stars with a hormone that would induce spawning. Then, they would freeze some of the sperm of the males there and take that — plus 10 live, adult starfish and larvae — back with them to the Lower 48.
But some of the massive, velvety echinoderms began the spawning process spontaneously — three days before the group would arrive.
'The nice thing is they had six males go off, and so [with] all that sperm, because we're going to be there on Monday, we can hit the ground running,' Kidd said.
The mission marks another step forward in a sprawling, multi-institution effort dedicated to recovering the species that scientists didn't realize were key for maintaining healthy kelp forests until they essentially disappeared overnight.
Sunflower sea stars — vividly colored creatures with up to 24 arms, and which can weigh as much as a small dog — once thrived along the Pacific Coast between Alaska and Baja California. Then, in 2013, a mysterious disease linked to a marine heat wave began to ravage the population. An estimated 5.75 billion sunflower sea stars perished, amounting to 94% of the global population. California lost about 99% of its Pycnopodia helianthoides to the wasting disease. Sunflower stars landed on the International Union for Conservation of Nature's critically endangered list in 2020.
Devastation begat devastation, as the ecological dominoes began to fall.
The carnivorous sea stars munch on purple urchins and might even ward them off by making them fearful using chemical cues. Urchins devour kelp, which sequesters carbon and serves as shelter and food for a vast array of marine life. Without sea stars to balance the food web, urchin numbers have exploded. On California's North Coast, where other urchin nemeses — like otters, spiny lobsters and sheephead — are lacking, 96% of the region's kelp forests vanished in the decade following the sea star collapse.
'It's kind of like the … 'you don't know what you have until it's gone' adage,' said Norah Eddy, associate director of the Nature Conservancy's oceans program in California.
However, she added, if the starfish population could be revived, it could 'turn the tide' on resuscitating kelp forests. And there are aspects of the creature's biology that make it a good candidate for that kind of comeback. A single breeding pair of sunflower stars can potentially produce thousands of offspring — many mouths to chomp down on urchins. By comparison, bringing a single otter back to the ecosystem can take significant time and investment.
Since its collapse, California's sunflower sea star population hasn't meaningfully bounced back on its own. But in recent years, major strides have been made in breeding the animals in captivity with the goal of eventually releasing them in the wild.
A spawning of sea stars on Valentine's Day of last year at the Birch Aquarium at UC San Diego's Scripps Institution of Oceanography marked a significant milestone. It was the first successful induced spawn of the animals in California.
Kylie Lev, curator at the Steinhart Aquarium at San Francisco's California Academy of Sciences, said it showed that researchers could facilitate breeding at a level to support reintroduction. A significant number of animals are needed because not all will make it in the wild, she said.
'We were all very happy, very surprised and shocked that this first large spawn right out the gate was able to produce so many animals,' she said. Institutions up and down the state — including the Academy, Cal Poly Humboldt, Aquarium of the Pacific in Long Beach and Monterey Bay Aquarium — took in fertilized embryos and were able to raise them into healthy stars that are still going strong.
'That kind of changed the perspective around whether or not it could be done to: it can be done, let's make sure it's done really thoughtfully,' she added.
Andrew Kim, a lab manager at Sunflower Star Lab, a nonprofit that leads research and conservation to recover the species, tilted his computer screen on a Zoom call to show dozens of young stars housed individually — due to rampant cannibalism — in what looked like plastic Tupperware.
'They're all full siblings,' he said.
In fact, all the juveniles in the state are, according to Kim. That's because only one male and one female were bred at the Birch Aquarium last year.
That makes them not exactly ideal for releasing en masse. The creatures don't migrate so if they were thrown into a tide pool they might only have each other to mate with, Lev said. In many species, inbreeding can reduce health and fitness.
Indeed, one of the key challenges facing the scientists working to reintroduce sunflower sea stars to the California coast is the lack of genetic diversity.
Enter the Alaska SeaLife Center, an aquarium with 40 sunflower sea stars — the largest collection of the animals in the world. The researchers will bring 10 of those back to the contiguous U.S., and five will go to the Golden State. That will roughly double the six currently under human care in California.
It's a pretty big deal, according to those involved. There were lots of regulatory hurdles that had to be cleared, involving collaboration with officials in Alaska and California. And this transfer of animals from Alaska to California should lay the groundwork for a more fluid transport of sea stars from places such as Washington and Oregon into California down the road, helping to further diversify the population there.
Researchers are galvanized by the high stakes. If the keystone species puts a check on urchins, allowing kelp forests to heal, we could recover an economic driver and a powerful tool for fighting climate change. Kelp captures carbon up to 20 times more than terrestrial forests. It's also a home for marine animals; without kelp, many disappeared — felling fisheries that some supported.
Releasing lab-raised stars into the ocean is still at least several years away. The infrastructure and know-how for rearing the creatures needs to be beefed up. Key research and logistical questions need to be answered. A biggie is understanding more about the nature of sea star wasting disease and how to build resilience to it among the starfish. Depending on how everything shakes out, Eddy surmises stars could be reintroduced to the Pacific within three to five years.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Los Angeles Times
4 hours ago
- Los Angeles Times
In ‘Murderbot,' an anxious scientist and an autonomous robot develop a workplace-trauma bond
Alexander Skarsgård was initially worried 'Murderbot' would be too dark. The actor had come off a string of intense films, including 'The Northman' and 'Infinity Pool,' and he was looking for something more comedic. The title of the series, based on Martha Wells' popular science fiction books, didn't suggest it would be particularly funny. 'I wasn't familiar with Martha's novellas, so I just heard the title and I heard 'sci-fi,' ' Skarsgård says, speaking over the phone from Los Angeles. 'If you're not familiar with the books, you think it's probably going to be an incredibly testosterone-driven, tough guy android kicking ass in space. But I was pleasantly surprised when I started reading [the script]. I had never encountered a character like this.' The actor was so struck by the titular character that he not only signed on to star in the Apple TV+ series but also joined as an executive producer alongside creators Paul Weitz and Chris Weitz. 'Talking to Chris and Paul and getting to know them got me even more excited,' he says. 'They're so brilliant, and their vision for the character and for the show got me fired up.' Season 1, which began streaming in May, is based on 'All Systems Red,' the first book in Wells' futuristic series 'The Murderbot Diaries.' It follows a private security cyborg, known as a 'SecUnit,' who hacks its governing module, allowing it newfound autonomy. An eclectic group of researchers, led by Dr. Mensah (Noma Dumezweni), are forced to accept the SecUnit as part of a planetary mission, and it slowly begins to learn the way of humans. The relationship between Mensah and their SecUnit, who refers to itself as Murderbot, is charmingly awkward. The pair are forced to trust each other as the mission goes awry, leading to an unlikely friendship. In 'Command Feed,' the sixth episode released on Friday, Mensah saves Murderbot from destruction by reluctantly performing surgery on its wiring. 'Is that what they call trauma bonding in this day and age?' Dumezweni says of the scene in a separate interview over Zoom from New York, where she is preparing to star in 'Duke & Roya' on Broadway. 'Filming it was extraordinary because the special effects guys were amazing. It [Murderbot] was literally in front of me, but that obviously wasn't Alexander. It looked so real.' 'That dynamic was led by the script, and it was very interesting,' Skarsgård adds. 'It was clear that Mensah would be an empathetic character. And Murderbot is not used to being treated respectfully by humans or even being treated as a sentient construct. He's always been a piece of equipment. Noma and I talked a lot about it. It was a gold mine to explore because there's so much comedy in their differences.' Leading a TV series is a first for Dumezweni, who has previously been cast in smaller roles. She wasn't convinced by the initial pitch at first because sci-fi hasn't traditionally had a lot of major roles for actors of color. 'Usually I'd come in and play the receptionist,' she says. 'I love to watch sci-fi. But I wondered: Who am I going to be in this sci-fi world?' However, once she learned more about the world and the character, the actor changed her mind. 'It was an absolute joy to discover that there was nothing that Chris and Paul had to change to make it representational,' Dumezweni says. 'It's lovely not to have to fight for people's positions in the world based on their skin color.' Both actors were drawn to the series in part because of its unique tone, which lands somewhere between action, comedy and drama. Murderbot is stoic but awkward and unaccustomed to human emotions, which it learns about by surreptitiously watching hours of soap operas. Mensah's Preservation Alliance team is composed of misfits, including David Dastmalchian's Gurathin and Sabrina Wu's Pin-Lee, who often confound Murderbot's expectations. The laughs don't come from intentional punchlines, but instead from situational circumstances and Murderbot's dry voice-over, as well as its disinterest in dealing with humans. 'The writing was so surprising and different and had such a unique tone from the beginning,' Skarsgård says. 'What works is that it has this instant combination of being a big, action-packed sci-fi show, but it's also a workplace comedy.' Because the voice-over is essential to the story, getting it right took a lot of trial and error. Skarsgård says he worried about how it would be incorporated during shooting, particularly because Murderbot is so expressionless and not very verbose in many of the actual scenes. 'How would we juxtapose that with an inner monologue that is more expressive?' he says. 'How do you find a fun and interesting balance between the way Murderbot speaks and the way he thinks?' The voice-over became an evolving component of the episodes. On set, an assistant director would sometimes read the narration off camera if it felt relevant for the actors to hear during a particular scene. After filming, Skarsgård, Chris and Paul got together in Stockholm, New York and Los Angeles for several recording sessions to try out different versions of the voice-over lines. 'It was quite exhausting, but also quite fun creatively because you could see how much the tone of the scene changed when we tweaked the voice-over a little bit,' Skarsgård says. 'You could have a moment where there's no voice-over, and it's like a non-moment where nothing happens. But then just by adding a little commentary by Murderbot, it suddenly pops into a funny little moment.' Although the series adheres to Wells' book, some aspects of the characters have been expanded. In the show, Mensah struggles with anxiety in a few vulnerable moments, which differs from her portrayal on the page. Dumezweni says she has observed some pushback from fans of the book about the changes, an experience she understands from playing Hermione Granger in 'Harry Potter and the Cursed Child' when it opened in the West End. 'That's what you have to do in film and TV,' she says. 'You have to expand, not change. You have to fill in. I love it because only Murderbot can see what's happening to her in that moment. None of her team can see it until Episode 4. I love those moments. For me, they grow her.' For Dumezweni, these scenes give Mensah a point of connection for the audience, as does the way Murderbot is 'autism-coded,' as some fans have noted. Skarsgård says the creators didn't set out to make the character overtly neurodivergent in the series. 'It's very clear when you read the novellas and the scripts that it is a character who is not always comfortable in settings with other people and can find interactions with humans tricky to navigate,' Skarsgård says. 'To me, it was a character we hoped would be relatable to people in the neurodivergent community, but also in a lot of fans in the LGBTQ community. Murderbot not having a gender or being subscribed to binary sexuality could be relatable, but it's natural to Murderbot. That was important — this is how Murderbot was created, and none of this [identity] is a big deal to Murderbot.' At the core of the show is the concept of Murderbot's free will, something that gets more fully explored in upcoming episodes. 'It's now understanding it has free will truly and that there are choices to be made in the world,' Dumezweni says. 'Meeting these people gives it a chance to understand that not all human beings are idiots.' 'For me, the inner journey for Murderbot over the course of the season is about what to do with that autonomy,' Skarsgård adds. 'The character has unleashed something inside of itself by hacking the governing module and gaining this independence. The journey becomes: I have this autonomy now, but who am I? What am I capable of? What am I willing to do? What are my desires?' Although 'Murderbot' has yet to be renewed for a second season, there is a lot of source material available. Wells has written seven books featuring Murderbot, and Skarsgård is excited about the potential for more episodes. 'I love Murderbot,' he says. 'I love playing Murderbot. Chris and Paul are not only supremely talented but incredibly nice and generous. If you talk to anyone who worked on the show, I guarantee that everyone had the time of their lives.' The remaining four episodes will reveal the antagonist behind the attacks on the Preservation Alliance and whether they'll successfully be able to escape the planet. They also offer essential backstory into characters like Mensah and Gurathin. 'I can't wait for people to see each and every story,' Dumezweni says. 'And what Alex does in the last two episodes is amazing. I don't care if I'm in no more seasons, but Alexander Skarsgård has to carry on making seasons of 'Murderbot.' He does so much with the tiniest movement of his face. He is extraordinary and he honors the character beautifully.' 'Murderbot's job will get harder and harder trying to protect these very lovely but also quite naive and inexperienced humans,' Skarsgård says. 'It's not a spoiler to say that eventually Murderbot will care about these humans, but we didn't want to rush into that. We leaned in slowly. So much of the comedy results from the character's absolute reluctance to save their lives.'


Hamilton Spectator
11 hours ago
- Hamilton Spectator
BC's sunflower sea stars are now endangered, but rays of hope remain
Sunflower sea stars clinging to life in BC's cold-water fjords are officially on the edge of extinction, a scientific advisory panel is warning. A once-abundant predator of the sea floor along the Pacific coast, stretching from Alaska to Baja California, Pycnopodia helianthoides, has been assessed as endangered by the federal Committee on the Status of Endangered Wildlife in Canada (COSEWIC). While disheartening, the decision isn't unexpected and could offer a margin of hope for the survival of the massive, vibrant sea star, said Alyssa Gehman, marine ecologist with the Hakai Institute. The only type of its genus, an adult sunflower star Pycnopodia (which comes in a variety of purple, orange or pinks) is one of the largest, fastest sea stars in the ocean, often reaching a metre wide with 16 to 24 arms. It has 15,000 tube feet that suspend it off the seafloor and allow it to move more than a metre per minute when on the prowl for prey, Gehman said. 'They kind of look like a hovercraft moving towards their food.' The species has suffered catastrophic population declines of 80 to 90 per cent in the last decade due to a marine epidemic known as sea star wasting disease that causes white lesions on the many-armed creatures before rapidly reducing them to mush. The wasting syndrome surfaced in 2013 along with spiking ocean temperatures caused by climate change, Gehman said. The disease attacks other types of sea stars as well, but it's decimated the sunflower variety, pushing them into virtual extinction in California and Mexican waters. Pockets of sunflower sea stars have found some refuge from the disease tucked away in the deep, cold inlets of the BC central coast, Gehman said. However, those remaining populations aren't immune to outbreaks and their chances of survival remain fragile. 'While [being endangered] is clearly bad news, the silver lining is that COSEWIC's acknowledgment might finally generate momentum to save Pycnopodia — whether that's in the form of funding, policy changes, or conservation programs,' Gehman said. The federal ministry of the environment and climate change will examine the committee's report in the fall to consider protecting the sunflower sea star under Canada's Species at Risk Act (SARA). It's illegal to kill, harm or capture wildlife listed under the act. Identifying critical habitat and devising a recovery strategy, complete with timelines and outcomes, is also required for a protected species. 'I hope it's a speedy process because there's real urgency,' Gehman said. 'From a conservation perspective, even though we have these really amazing refuge populations that give us a lot of hope, they're not stable … So, the more we can learn about what is happening with them, the more that can help us to try and conserve the species.' The sunflower sea stars are carnivores that play an important role in ocean health, said Gehman. Their primary prey is sea urchins which, if left unchecked by predators, can mow down kelp forests that offer food and shelter for lots of different marine life. Gehman and other researchers are monitoring between six and 12 fjords to pinpoint the conditions that offer sunflower sea stars the most protection against the disease. Water chilled and churned up by Arctic winter winds channelled into the inlets seems to buffer the impacts, she said. In warmer weather, glacial melt creates a freshwater surface layer in the fjords. Since Pycnopodia don't like fresh water, the sea stars move deeper into saltier, colder water layers, which appears to slow but not completely prevent outbreaks, Gehman said. Typically, sunflower stars in other areas of the coast prefer water temperatures around 16 C. But now it appears that water temperatures must be less than 12 C to limit the spread of the pathogen. 'The disease is actually changing what temperature would be best for them,' Gehman said. The sea stars haven't adapted quickly enough to the disease to consistently avoid warmer waters, which makes understanding the factors at play in their cold-water hideouts critical for their survival, she said. Research is taking place south of the border to breed sunflower sea stars that are more resistant to the wasting disease, so they can potentially be released into the wild to repopulate marine areas. In future, Gehman wants to study other kinds of sea stars — like the purple or orange ochre sea stars on the West Coast— that have better withstood the withering disease in a bid for clues scientists could use to help out their much larger cousins. Identifying and protecting coastal fjords that offer the best conditions for sunflower sea stars is also an important step. Although the Pycnopodia situation is grave, Gehman says she recently experienced a rare and magical moment when the research team witnessed a massive spawning event involving 20 to 30 sea stars, while surveying one of the fjords. 'It's absolutely wild,' Gehman said, The sunflower sea stars have pores that circle the centre of their body. The marine creatures stretch upward on extended arms and arch their bodies, with females releasing masses of pinkish eggs while males emit white clouds of sperm. 'Only the tips of their arms are on the bottom with their middle body tented up into the water column,' she said. 'There were some absolutely giant animals. It kind of looks like there's a halo of pores on them, and everything is pouring out into the water — it's really surreal.' The spawning event is a hopeful sign these cold-water strongholds can offer the endangered species some measure of resiliency from climate change and disease, she said. But the situation remains tenuous and variable, said Gehman, noting on the same trip researchers found sunflower sea stars had been wiped out in one inlet but had bounced back in another. 'So, scientifically, we're learning a lot while also being sad,' she said. Rochelle Baker/Local Journalism Initiative/Canada's National Observer Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Yahoo
4 days ago
- Yahoo
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"
Featuring Serina Therapeutics' CEO - Wednesday, June 11, 2025 Entering year 5 of a biotech bear market, approximately 25% of the 700 – 800 publicly traded US biotech companies have negative enterprise values Recognize the patterns that can lead to strong investment returns Meet with Serina's CEO Steven A. Ledger Register at HUNTSVILLE, AL, June 09, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ('Serina') (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, is pleased to announce that Serina's CEO, Steven A. Ledger will present at Tribe Public's Webinar Presentation and Q&A Event titled "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?" The Event is scheduled to begin at 8:30 am pacific / 11:30 am eastern on Wednesday, June 11, 2025. To register to join the complimentary event, please visit the Tribe Public LLC at Once registered, participants may begin forwarding their questions for the CEO to Tribe Public at research@ or share their questions via the ZOOM chat feature during the event. Tribe Public's Managing Member, John F. Heerdink, Jr., will host the event and relay all questions to management. About Serina Therapeutics Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina's POZ Platform™ provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology. For more information, please visit About Tribe Public LLC Tribe Public LLC, headquartered in San Francisco, California, is a distinguished organization that facilitates corporate sponsored global webinars and in-person meetings events across 36 premier venues throughout the United States. Tribe Public's events are tailored to address topics of significant interest to its members, with a particular emphasis on providing direct access to management teams and leading experts from diverse sectors who seek to enhance awareness of their products, achievements, and strategic initiatives. The Tribe's membership is composed primarily of Family Offices, Portfolio Managers, Registered Investment Advisors, Accredited Investors, Sell Side Analysts, and media professionals, all of whom benefit from exclusive opportunities for business development, community building, and informed dialogue in a collegial setting. Members are actively encouraged to shape the event agenda by submitting speaker and company preferences through Tribe Public's complimentary 'Wish List' process on its website, ensuring that the programming reflects the evolving interests of its sophisticated community. To learn more about Tribe Public's offerings and to participate in upcoming events, visit their website at: Cautionary Statement Regarding Forward-Looking Statement This release contains forward-looking statements within the meaning of federal securities laws. These statements are based on management's current expectations, plans, beliefs or forecasts for the future, and are subject to uncertainty and changes in circumstances. Any express or implied statements in this press release that are not statements of historical fact, including statements about the potential of Serina's POZ polymer technology, are forward-looking statements that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from our clinical studies; whether and when any applications may be filed for any drug or vaccine candidates in any jurisdictions; whether and when regulatory authorities may approve any potential applications that may be filed for any drug or vaccine candidates in any jurisdictions, which will depend on a myriad of factors, including making a determination as to whether the product's benefits outweigh its known risks and determination of the product's efficacy and, if approved, whether any such drug or vaccine candidates will be commercially successful; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of any drug or vaccine candidates; and competitive developments. These risks as well as other risks are more fully discussed in Serina's Annual Report on Form 10-K, and Serina's other periodic reports and documents filed from time to time with the SEC. The information contained in this release is as of the date hereof, and Serina assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. The information contained in this release is as of the date hereof, and Serina assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. For inquiries, please contact:Stefan Riley sriley@ (256) 327-9630Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data